LncRNA surfactant associated 1 activates large tumor suppressor kinase 1/Yes-associated protein pathway via modulating hypoxic exosome-delivered miR-4766–5p to inhibit lung adenocarcinoma metastasis-Reference-Cited by-同舟云学术

LncRNA surfactant associated 1 activates large tumor suppressor kinase 1/Yes-associated protein pathway via modulating hypoxic exosome-delivered miR-4766–5p to inhibit lung adenocarcinoma metastasis

Published:2022-12 Issue: Volume:153 Page:106317
ISSN:1357-2725
Container-title:The International Journal of Biochemistry & Cell Biology
language:en
Short-container-title:The International Journal of Biochemistry & Cell Biology

Author:

Zhang Weiqiang,Bai Miaochun,Liu Keqiang,Tan Jian,Ma Jingbo,Zhao Jing,Hou Peifeng

Publisher

Elsevier BV

Subject

Cell Biology,Biochemistry

Reference35 articles.

1. Epidemiology: The dominant malignancy;Bender;Nature,2014

2. Hippo pathway in cancer: aberrant regulation and therapeutic opportunities;Calses;Trends Cancer,2019

3. circ_0000467 promotes the proliferation, metastasis, and angiogenesis in colorectal cancer cells through regulating KLF12 expression by sponging miR-4766-5p;Chen;Open Med. (Wars., Pol. ),2021

4. Long Non-Coding RNA in the pathogenesis of cancers;Chi;Cells,2019

5. Expression of long non-coding RNA SFTA1P and its function in non-small cell lung cancer;Du;Pathol., Res. Pract.,2020

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Crosstalk between lncRNAs and Wnt/β-catenin signaling pathways in lung cancers: From cancer progression to therapeutic response;Non-coding RNA Research;2024-09

2. Differential expression and clinical significance of long non-coding RNAs in the development and progression of lung adenocarcinoma;Frontiers in Oncology;2024-06-06

3. Identification and verification of a PANoptosis-related long noncoding ribonucleic acid signature for predicting the clinical outcomes and immune landscape in lung adenocarcinoma;Heliyon;2024-04

4. Identification of an Exosome-relevant SNHG6-hsa-miR-429- CHRDL1/CCNA2 Axis for Lung Adenocarcinoma Prognosis Evaluation;Current Medicinal Chemistry;2023-11-27